Most Americans who know Cigna know it as a rectangle in a wallet. It appears at a doctor's reception desk, on an employer enrollment screen or beside a claim whose arithmetic requires patience. That familiar card, however, now describes only part of the company. The Cigna Group is also a pharmacy-benefit manager, a specialty pharmacy, a behavioral-health network, a virtual-care provider, a clinical-rule engine and a supplier of health services to other organizations. The card is the storefront. The larger business is backstage.
That distinction became especially visible in 2025. The company reported $274.9 billion in total revenue, up 11 percent from a year earlier. Cigna Healthcare, the benefits division, produced $47.2 billion in adjusted revenue. Evernorth Health Services produced nearly $235 billion. Those figures include transactions between segments and should not be added together, but the imbalance still reveals where the scale lives: in prescriptions, specialty medicines and services that travel far beyond Cigna's own medical membership.
Two engines, one corporate roof
Cigna Healthcare is the part most people recognize. It provides medical plans and coordinated benefits to employers, individuals and families in the United States, plus health coverage for international markets and globally mobile workers. It makes money from premiums on insured plans and fees for administering plans whose claims are funded by employers. Dental coverage, stop-loss protection and provider-network access sit in the mix. At the end of 2025, it counted 18.1 million medical customers.
Evernorth serves a broader cast: employers, health plans, government organizations, providers and patients. Its best-known brand is Express Scripts, the pharmacy-benefit manager Cigna acquired in a $67 billion combination in 2018. Accredo handles specialty medicines for complex and rare conditions. eviCore supplies evidence-based medical-benefit management. MDLIVE delivers virtual medical and behavioral care. Other businesses cover drug distribution, home delivery, behavioral health, workplace clinics and care navigation.
Cigna Healthcare
Medical plans, networks, benefits and administration for employers and individuals.
Evernorth
Pharmacy, specialty medicine, behavioral care, virtual visits and clinical services.
The structure gives Cigna two ways to participate in a health-care dollar. It can finance and administer care through the health plan, and it can provide the services used by that plan. Crucially, Evernorth does not depend only on Cigna Healthcare. It can sell to competing plans and outside employers, spreading its pharmacy networks, clinical expertise and technology across a much larger customer base.
Different doors into the same company / millions
The problem is the handoff
Health care's signature frustration is not always a lack of capability. It is the gap between capabilities. A doctor writes a prescription, a benefit manager applies the formulary, a pharmacy fills it, a plan adjudicates it, an employer pays part of it and a patient tries to understand the bill. Complex illness adds specialists, infusion sites and case managers. Every handoff creates another opportunity for delay, duplication or surprise.
Cigna's pitch is that a company holding more of those threads can coordinate them. Pharmacy claims can reveal when a patient is not taking a medicine. Clinical programs can steer someone toward a less expensive care site. Behavioral and physical care can be viewed together. A specialty pharmacy can pair a difficult drug regimen with condition-specific support. The goal is not merely convenience. It is to improve outcomes while controlling costs for the employer or health plan buying the service.
“The status quo in health care today is unsustainable.”David Cordani, announcing the 2026 leadership transition
Integration is also the company's point of difference and its central test. UnitedHealth Group has Optum, CVS Health combines Aetna and Caremark, and Elevance Health has Carelon. All are assembling versions of the same proposition: insurance plus services plus data. Cigna differs in its portfolio emphasis. After selling its Medicare Advantage, Part D and supplemental-benefits businesses to Health Care Service Corporation in 2025, it carries less direct exposure to government-sponsored insurance than several large rivals. Evernorth nevertheless kept a pharmacy-services relationship with the divested Medicare business. The insurance asset moved; part of the services connection remained.
The useful way to think about Cigna
It is not a health insurer with a collection of side businesses. It is an enterprise health-services platform anchored by a health insurer. The distinction explains its customer count, revenue mix and acquisition history.
Who hires a company this large?
The answer is usually another institution. A large employer may hire Cigna Healthcare to administer a self-funded medical plan, rent its provider network and protect against unusually high claims. The employer still supplies the claim dollars; Cigna supplies the operating system and earns administrative fees. A smaller employer may instead buy a fully insured plan, transferring more of the medical-cost risk to Cigna in exchange for premiums. Brokers and benefits consultants often sit between the two.
Evernorth can enter through a different door. A health plan can use Express Scripts to process drug claims, negotiate a pharmacy network, build a formulary and run home delivery. A hospital system can work with Shields on its specialty pharmacy. A benefits buyer can add MDLIVE virtual visits or behavioral-health access without buying Cigna medical coverage. Government clients are part of the mix, too: Express Scripts holds the TRICARE pharmacy contract serving military members, their families and retirees through 2029.
That modularity is commercially important. Cigna can bundle capabilities when a client wants fewer vendors, but it can also sell a single component into an organization that has chosen another medical carrier. Revenue follows the job being done: insurance premiums, administrative charges, pharmacy and distribution revenue, specialty-drug sales, and fees for clinical or benefit services. It is a business designed for recurring, high-volume relationships rather than one-time consumer purchases.
Products for the expensive edge
Much of the growth opportunity sits where care is most complicated. Specialty drugs treat cancer, autoimmune disorders and rare diseases, but they can demand careful handling, prior authorization and ongoing clinical support. Accredo operates in that difficult channel. In 2025, Evernorth also invested in Shields Health Solutions, which helps hospitals build and run specialty-pharmacy programs. The move brought Cigna closer to providers and to the sites where specialty patients already receive care.
The company is also packaging responses to highly visible cost problems. EncircleRx combines a financial guarantee for employers with digital lifestyle support around GLP-1 medicines used for diabetes and weight management. Clearity by Cigna Healthcare, introduced in 2025, is a copay-only plan intended to replace much of the usual deductible-and-coinsurance fog with fixed prices. Its digital tools use AI to guide customers toward care and estimate what they will owe.
These products show how the business sells to two audiences at once. The patient wants a clear price, an available clinician and medicine that arrives. The employer or health plan wants predictable spending, appropriate use and evidence that the service helped. Cigna's products become valuable when they satisfy both without making one audience's experience worse for the other's benefit.
A long history of becoming something else
The company's family tree begins long before employer health benefits. Insurance Company of North America was founded in Philadelphia in 1792 as a marine insurer. Connecticut General was incorporated in 1865. The two combined in 1982, and the name Cigna was assembled from CG and INA. That bit of corporate wordplay has survived a remarkable sequence of portfolio changes.
The decisive modern turn came with Express Scripts. Cigna followed by launching Evernorth in 2020, acquiring MDLIVE in 2021 and adopting its current three-brand architecture in 2023: The Cigna Group above Cigna Healthcare and Evernorth Health Services. The arrangement makes an old insurer legible as a newer kind of company, though the operating complexity remains.
Scale does not dissolve the industry's tensions. Pharmacy-benefit managers face sustained scrutiny over rebates, pricing and the economics of independent pharmacies. Insurers face anger over denials, prior authorization and bills that arrive without intuitive explanation. Cigna has responded with its multi-year “Commitments to Better,” including simpler access, more support for complex conditions, improved value and an annual transparency report. It had already removed 25 percent of medical services from prior authorization in 2023 and joined other large plans in 2025 to promise further simplification.
The next hand on the wheel
Brian Evanko became chief executive on July 1, 2026, after nearly three decades at the company. David Cordani, CEO for almost 17 years, moved to executive chair. Evanko has named three problems: affordability, fragmented customer experiences and a system built around sickness more than prevention. They happen to line up with the assets he inherited.
The opportunity is to turn the company's breadth into a better sequence of small moments: a medicine that costs what the member expected, a prior authorization that does not stall treatment, a behavioral-health appointment found before a crisis, a chronic condition managed before a hospital visit. The risk is that the machinery remains visible mainly when it refuses, delays or confuses.
That makes The Cigna Group a revealing company for this moment in American health care. Its market position rests on the belief that fragmentation can be managed with greater integration, richer data and aligned services. Its public burden is proving that the resulting scale works for the person holding the card, not only for the organizations paying the invoice. The company behind the card is already vast. The more consequential question is whether it can make that vastness feel simple.